Laura J van 't Veer, MD on Availability on MINDACT in Breast Cancer #ASCO2020 @UCSFMedicine

Laura J van 't Veer, MD on Availability on MINDACT in Breast Cancer #ASCO2020 @UCSFMedicine

User Photo
Cancer-News

3 months
26 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Laura J van 't Veer, MD of UCSF Helen Diller Family Cancer Center @UCSFMedicine discusses MINDACT: Long-term results of the large prospective trial testing the 70-gene signature MammaPrint as guidance for adjuvant chemotherapy in breast cancer patients presented at this year's virtual ASCO.
Up Next Autoplay